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ABSTRACT
Maternal Toxoplasma gondii (T. gondii) infection can lead to spontaneous abortion, 
fetal malformation, and numerous sequelae in the newborn, including visual and hearing 
impairment. T. gondii serology was determined in pregnant women and their newborns who 
were referred to Climério de Oliveira Maternity, Federal University of Bahia, and the possible 
associations with the risk factors for maternal infection were investigated. This cross-sectional 
study was conducted from January to December 2014 and included 712 pregnant women, 
aged 15 to 49 years, and 235 newborns. Seroprevalence was determined by the detection of 
T. gondii-specific immunoglobulin (Ig) M (IgM) and IgG antibodies using enzyme-linked 
immunoassay. In addition, mothers completed a questionnaire that focused on socioeconomic 
aspects, and survey data were tabulated using the SPSS statistical software program (version 
21.0 for Windows). The seroprevalence rate for specific IgG antibodies was 51% (362) among 
mothers and 93% (219) among neonates. All the mothers and their newborns were negative 
for specific-IgM antibodies. Higher age group and lower maternal education were the only 
risk factors statistically associated with the presence of specific IgG. In summary, high levels 
of specific IgG antibodies were observed in pregnant women. The knowledge of risk factors 
for toxoplasmosis can help in the orientation of newly pregnant women.
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INTRODUCTION
The protozoan Toxoplasma gondii (T. gondii), causative agent of toxoplasmosis, 
was first identified at the Pasteur Institute in Tunis, Tunisia, by the French researchers 
Nicolle and Manceaux and in Brazil by Splendore, in 1908, according to Weiss 
and Dubey1. This intracellular parasite can infect different tissues in a variety of 
vertebrate animals, including humans2. The ability of this parasite to multiply 
within all nucleated cells of hosts is noteworthy3. Members of the Felidae family 
are considered definitive hosts, whereas birds, livestock, and the great majority 
of homoeothermic vertebrates are intermediate hosts4. In addition to being a 
zoonosis, toxoplasmosis is a systemic infectious disease. It is associated with all 
continents and most types of climate, with a higher prevalence in hot and humid 
climate5. This infection can be transmitted by the passage of one of the forms of 
T. gondii (i.e., oocysts, bradyzoites, and trophozoites) through inhalation, ingestion, 
transfusion, and organ transplantation from one individual to another or vertically 
from the infected mother to the fetus or newborn6. Depending on the immunological 
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competence of the host, signs and symptoms may range 
from absent to severe. Immunocompetent individuals 
usually present an initial or acute phase of asymptomatic 
disease7. The percentage of these individuals varies between 
80% and 90%. Nevertheless, in immunocompromised 
individuals, disease manifestations can be severe8.
The occurrence of a T. gondii infection during gestation 
deserves special attention from public health agencies, 
whether individually or collectively. Pregnant women 
who are T. gondii seronegative raise the greatest concern. 
A first-time T. gondii infection during the gestational 
period without the protection of specific IgG antibodies 
may compromise embryogenesis, fetal development and 
increase neonatal morbidity and mortality. According to 
Higa et al.9, the prevalence of infection in the population 
and the frequency of contacts with possible sources of 
contamination are factors associated with acquisition 
of the infection. Remington et al.10 have suggested the 
possibility of vertical transmission of toxoplasmosis 
resulting from a reactivation of the disease in chronically 
infected mothers caused by the expressive reduction 
of immunity. Immunocompetent people are usually 
asymptomatic. Thus, infection in pregnant women 
often goes undetected, and a possible maternal-fetal 
transmission may be recognized with the appearance of 
early or late sequelae in the neonate11.
This work aimed to establish the seroprevalence for 
toxoplasmosis in mothers and their respective newborns 
who were referred to the Climério de Oliveira Maternity 
(MCO), Federal University of Bahia (Salvador-Bahia), 
Brazil, from January to December 2014, and to associate 
maternal seroprevalence with risk factors of infection.
MATERIAL AND METHODS
The present study is part of a project entitled “Agents of 
congenital infection in pregnant women in Salvador, Bahia: 
research on the prevalence and analysis of risk factors.” This 
study was approved by the Ethics Committee of the Federal 
University of Bahia (UFBA), School of Nursing, in 2013, 
under the protocol Nº 384.209. 
This cross-sectional study was carried out from January 
to December 2014 at the Climério de Oliveira Maternity, 
UFBA, Salvador, Bahia. The study participants were 712 
pregnant women from Salvador and other municipalities in 
the State of Bahia, assisted by the Unified Health System 
(SUS), and 235 newborn infants (NB) from seropositive 
mothers. Pregnant women with insufficient blood samples 
to perform tests were excluded from the study. 
Pregnant women were informed on the nature of the 
study and those who agreed to participate signed the 
consent form and completed the questionnaire addressing 
socioeconomic aspects and risk factors of contracting 
T. gondii infection.
For the detection of IgG antibodies, a third-generation 
indirect enzyme-linked immunoassay (recombinant 
antigen) was used, and IgM was detected according to 
the manufacturer’s instructions (Symbiosys, Leme, State 
of São Paulo, Brazil). Optical densities were measured 
by using the 450-nm and 630-nm filters and the ALISEI 
automated system (Seac Radim, Italy).
After data tabulation, SPSS statistical software (version 
21.0 for Windows) was used for analyses. The normality 
of continuous data was evaluated using the Kolmogorov-
Smirnov test. The chi-square test was used for comparisons 
between proportions, and the level of statistical significance 
was set at p ≤ 0.05.
RESULTS
All the participants (712 pregnant women aged 15 to 49 
years and 235 newborns) presented negative anti-T. gondii 
IgM antibodies. Of the total maternal sera analyzed, 362 
were positive for specific IgG and 350 were negative, 
resulting in a seroprevalence rate of 51%.
 Among two hundred and thirty-five newborns of 
seropositive mothers, IgG anti-T. gondii was positive in 
219 (93%) and negative in 16 (7%).
Table 1 shows that the presence of anti-T. gondii 
antibody was positively associated with the level of 
education and the age group of pregnant women who 
participated in the study.
DISCUSSION
The seroprevalence of 51% for T. gondii infections 
found in pregnant women is consistent with the results 
of Dubey et al.12. These authors mentioned a variation of 
anti-T. gondii IgG seroprevalence in pregnant women, in 
the Brazilian regions, ranging from 50% to 80%. In 2002, 
Nascimento et al.13 carried out a study in pregnant women 
who attended SUS in Salvador, came from different cities 
of Bahia and reported a seroprevalence of 64.9%. However, 
the seroprevalence in pregnant women from Porto Alegre 
was 59.8% as reported in 2003 by Varella et al.14. In 2012, 
in the city of Aracaju, Sergipe, Tavares et al.15 reported a 
IgG anti-T. gondii seroprevalence of 43.5% in pregnant 
women who attended SUS, which was a much lower rate 
than the ones reported by previously mentioned studies. 
Prevalence rates also differ between countries. Flatt and 
Shetty16 reported, in a study published in 2012, an IgG 
seroprevalence rate of 17.32% for T. gondii in pregnant 
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women in London. In Kinshasa, the Democratic Republic 
of Congo, this rate was 80.3%, according to the study of 
Yobi et al.17. The specific IgG seroprevalence reported by 
Yad Yad et al.18 in a study involving pregnant women in the 
Southern province of Khuzestan, Iran, was 27.3%.
According to Yobi et al.17, the hygienic conditions in 
the environment contribute to a lesser or greater exposure 
to the parasite and, by extension, to the seroprevalence in 
each region. 
As expected, in this study, there was a high seropositivity 
rate of anti-T. gondii IgG in the newborn infants of 
seropositive pregnant women (93%) due to the passage of 
these maternal antibodies through transplacental routes.
The lack of the detection of anti-T. gondii IgM 
among the neonates indicates that there was no vertical 
transmission of toxoplasmosis. This finding is consistent 
with the fact that specific IgM was not detected in any of the 
pregnant women who participated in the study, an indicator 
of a T. gondii primary infection or reactivation, which could 
increase the risk of vertical transmission. Andrade et al.19 
reported a case of vertical transmission in a mother who 
had retinochoroiditis due to T. gondii reactivation during 
Table 1 - Anti-T. gondii IgG in pregnant women versus risk factors for infection
Risk factors for infection by T. gondii 
Dosage IgG anti-T. gondii
Positive Negative Total OR (95% CI) p-value
Do you breed dogs and/or cats? 0.365
    Yes 182 (51.6%) 171 (48.8%) 353
    No 168 (48.1%) 181 (51.9%) 349
Do you consume undercooked meat? 0.678
    Yes 88 (58.5%) 84 (48.8%) 172
    No 264 (49.3%) 269 (50.7%) 531
Contact with soil / manure? 0.170
    Yes 86 (58.5%) 61 (41.5%) 147
    No 264 (47.5%) 292 (52.5%) 556
Education
    Complete 3rd grade 12 (38.7%) 19 (61.3%) 31
    Incomplete 3rd grade 19 (38.8%) 30 (61.2%) 49 0.995
    Complete 2nd grade 159 (49.1%) 165 (50.9%) 324 0.272
    Inomplete 2nd grade 59 (46.5%) 68 (53.5%) 127 0.497
    Complete 1st grade 25 (46.3%) 29 (53.7%) 54 0.149
    Incomplete 1st grade 74 (63.8%) 42 (36.2%) 116 0.010* 
    Illiterate   2 (100.0%) 0 (0.00%) 2 0.197
Family Income (minimum wage) 0.330
    < 1 20 (43.5%) 26 (56.5%) 46
    1 – 3 298 (51.0%) 286 (49.0%) 584
    4 a 6 30 (47.6%) 33 (52.4%) 63
    > 6 2 (25.0%) 6 (75.0%) 8
Place of residence 0.331
    Capital 303 (49.1%) 314 (50.9%) 617
    Interior 46 (54.8% 38 (45.2%) 84
Age Range (years)
    15 – 24 99 (39.6%) 151 (60.4%) 250 Ref.
    25 – 34 172 (53.6%) 149 (46.4%) 321 1.76 (1.25 – 2.46) < 0.010*
    35 – 44 74 (59.7%) 50 (40.3%) 124 2.26 (1.45 – 3.50) < 0.010*
    ≥ 45 5 (62.5%) 3 (35.5%) 8 2.54 (0.59 – 10.87) 0.208
Source: Research data. *Significant association (p < 0.05)
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the gestational period, representing a rare case of congenital 
infection.
In the analysis of the risk factors, an association between 
anti-T. gondii IgG seropositivity and dog and/or cat breeding 
was not demonstrated. Our finding corroborates data of Flatt 
and Shetty16, involving 2,610 pregnant women in the city of 
London, United Kingdom, and Porto et al.20, involving 503 
pregnant women attending a maternity ward in Recife, State 
of Pernambuco, Brazil, between October 2004 and April 
2005. Although Tavares et al.15 reported a positive association 
in a study involving 395 pregnant women from Aracaju, State 
of Sergipe, Brazil, who attended SUS in 2011.
The habit of ingesting undercooked meat was not a risk 
factor for toxoplasmosis, which agrees with the study of de 
Quadros et al.21, involving 148 pregnant women. However, 
an outbreak of toxoplasmosis due to the ingestion of raw 
meat occurred in the city of São Paulo, State of São Paulo, 
Brazil, where six patients acquired acute toxoplasmosis, 
including a pregnant woman; despite maternal treatment, 
fetal death occurred22.
In our study, the habit of handling soil or manure did 
not constitute a risk factor for toxoplasmosis as evidenced 
by antibodies against T. gondii. The difference in the 
seropositivity of the pregnant women who handled these 
materials (58.5%) and those who did not (47.5%) was not 
statistically significant. A similar result was demonstrated in a 
study by Porto et al.20 who reported that pregnant women who 
had a habit of handling soil (16.8%) versus those who did not 
(24.5%) did not generate a statistical significance (p = 0.07).
Regarding the family income, the seropositivity of 
participants with a family income below one minimum 
wage (43.5%) was similar to those whose income was 
greater than six minimum wages (25%). A similar result 
was reported by Rhodes and Shetty16 but they argued that 
the difference was not statistically significant because only 
eight patients had income of more than six minimum wages. 
It was not possible to indicate in this research whether the 
family income increment would make a difference in this 
population.
As for the place of residence, Yad Yad et al.18 reported no 
significant differences in the specific IgG seroprevalence in 
a rural area (p < 0.5) versus an urban area (p = 0.06). These 
results are possibly due to the scarcity of studies involving 
these variables, given that most of the work is carried out in 
developed countries where social equality is more prevalent.
T. gondii seropositivity showed a negative association 
with educational level, with a decreasing tendency of 
seropositivity as the level of education increased (Table 1) 
and revealed a significant statistical correlation (p = 0.01). 
This finding is in line with the results of Varella et al.14 
and Porto et al.20 (p = 0.0013); both studies demonstrated 
lower rates of toxoplasmosis seropositivity in pregnant 
women with eight or more years of education (26.1%) 
than in those with up to seven years of study (12.6%). On 
the other hand, de Quadros et al.21 demonstrated that there 
were no differences for specific IgG production among 
pregnant women who had not completed primary education 
compared to those who had completed high school. This 
divergence probably reflects differences in habits of the 
studied populations and the negative association could 
be explained by better hygiene habits and a consequent 
reduction in the degree of exposure to T. gondii. Pregnant 
women with a higher educational level have better access 
to information.
This study demonstrated a IgG anti-T. gondii 
seroprevalence of 51% in pregnant women and of 93% in 
their newborn infants. There was no detection of serological 
markers of primary maternal infection (IgM) in pregnant 
women included in the study. Among the neonates of these 
chronically infected mothers, none had anti-T. gondii IgM. 
Risk factors that had a statistically significant association 
with T. gondii infection were education level and age group. 
The fact that several risk factors were not associated with 
T. gondii infection might depend on characteristics and 
habits of different populations.
Besides contributing with important information about 
the vertical transmission of toxoplasmosis, risk factors 
involved and adoption of preventive measures, this study 
raises a question about the seronegative status of 7% of the 
newborn infants of IgG-positive mothers. Although IgG can 
cross the placenta, not all subclasses (e.g., IgG1, IgG2, IgG3, 
and IgG4) are equally efficient in this process; for example, 
IgG2 does not easily cross the placenta. This curious finding 
deserves further investigation. It is noteworthy that not all 
newborns of mothers seropositive for IgG anti-T. gondii tested 
positive for this serological marker. This finding shows that 
there is not always a transplacental transfer of maternal IgG 
to the fetus, which can be explained by the different structural 
and functional characteristics of IgG subclasses, such as 
the ability to cross the placenta. The IgG2 isotype is least 
effective at crossing the placental barrier. Although the lack 
of IgG maternal transmission to the fetus could be related 
to the antibody titer; that is, women who had higher IgG 
concentration would be more likely to generate a naturally 
acquired passive immunity in their newborns23. Future studies 
are needed to clarify these issues.
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